Table 2.
Hematologic, renal, and cardiac response and progression rates.
| Old criteria (per protocol) | New criteria | |
|---|---|---|
| Hematologic | ||
| N | 92 | 92 |
| Responders | 48 (52%) | 57 (62%) |
| CR | 6 | 15 |
| VGPR | 12 | 22 |
| PR | 30 | 20 |
| Renal | ||
| N | 62 | 62 |
| Responders | 15 (24%) | 31 (50%) |
| Time to response, median (range) | 161 days (28–502) | 62 days (28–480) |
| Progression | 14 (23%) | 27 (44%) |
| Time to progression, median (range) | 196 days (21–1022) | 144 days (26–1230) |
| Cardiac | ||
| N | 71 | 71 |
| Responders | 11 (15%) | 6 (8%) |
| Time to response, median (range) | 213 days (58–995) | 196 days (35–510) |
| Progression | 10 (14%) | 19 (25%) |
| Time to progression, median (range) | 232 days (84–697) | 30 days (23–396) |